Pure Global AI
NCT06117995Not yet recruiting

Sperm Motility and IUI Live Birth Rate

Intrauterine Insemination Outcomes Based on WHO 2021 Manual Assessment of Total Rapidly Progressing Motile Sperm Count
Mỹ Đức HospitalClinicalTrials.govother
Verified
Study focus
Disease/Condition
Infertility
Drug/Device/Intervention
Assessment the pre-washed sperm motility before IUI
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Mỹ Đức Hospital
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Dec 30, 2025
Enrollment
536 participants
Primary outcome

Live birth rate

Summary

This prospective cohort study aims to establish a cut-off threshold for pre-washed total
 rapidly motile sperm count (TRMSC) based on WHO 2021 criteria to predict the live birth rate
 following intrauterine insemination (IUI). The study seeks to answer two key questions:
 
 1. Is there a correlation between TRMSC, as per the WHO 2021 criteria, and the live birth
 rate after IUI?
 
 2. What is the appropriate cut-off threshold of TRMSC to predict a positive live birth
 outcome after IUI? Couples undergoing ovulation induction and IUI for indicated reasons
 will participate in the study. On the day of insemination, the pre-washed semen from the
 husband will be assessed according to the WHO 2021 criteria. The outcomes of the IUI
 procedure will be documented.

ICD-10 classifications
Female infertilityMale infertilityFemale infertility, unspecifiedFemale infertility of other originFemale infertility of uterine origin
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06117995
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06117995 through Pure Global AI's free database. This phase not specified trial is sponsored by Mỹ Đức Hospital and is currently Not yet recruiting. The study focuses on Infertility. Target enrollment is 536 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.